Pharmaceutical-grade pre-miR-29 purification using an agmatine monolithic support.

Area of Science:

• Biochemistry
• Chromatography
• Molecular Biology

Background:

• MicroRNA-based therapeutics require high-purity microRNA (miRNA) for clinical applications.
• Pre-microRNA-29 (pre-miR-29) is implicated in various diseases, making its purification critical.
• Conventional particle-based columns face limitations in miRNA purification.

Purpose of the Study:

• To develop a novel, efficient, and selective method for purifying pre-miR-29.
• To utilize monolithic columns combined with agmatine ligands for specific miRNA capture.
• To optimize purification strategies for high yield and purity of pre-miR-29.

Main Methods:

• Development of an affinity chromatography method using agmatine-functionalized monolithic columns.
• Evaluation of flow rates and RNA concentrations on binding capacity.
• Implementation of stepwise gradients (NaCl, arginine, ammonium sulfate) for binding and elution.
• Quality control analysis for impurities (proteins, endotoxins, sRNA).

Main Results:

• The novel method efficiently purifies pre-miR-29 from other small RNA species and bacterial impurities.
• Dynamic binding capacity is dependent on feed RNA concentration.
• Elution strategies using sodium chloride or arginine yielded high pre-miR-29 purity (up to 90.11%) and yield (up to 97.33%).
• Final product exhibited negligible levels of impurities.

Conclusions:

• Agmatine-based monolithic affinity chromatography is a powerful tool for pre-miR-29 purification.
• This method provides a rapid, economical, and efficient platform for miRNA purification for clinical use.
• The developed technique addresses the need for high-quality, biologically active miRNAs in therapeutic development.